Purification and characterization of a kinin- and angiotensin II-forming enzyme in the dog heart

Journal of Hypertension

Volumn 15, Issue 6, 1997, Pages 675-682

  Sasaguri, Manabu ^a   Maeda, Hirokazu ^a   Noda, Keita ^a   Tsuji, Emiko ^a   Kinoshita, Akio ^a   Ideishi, Munehito ^a   Ogata, Shigenori ^a   Arakawa, Kikuo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Angiotensin; Dog; Heart; Kallikrein; Kinin

Indexed keywords

ANAZOLENE SODIUM; ANGIOTENSIN; APROTININ; CATHEPSIN D; CATHEPSIN G; CHYMASE; GLYCOPROTEIN; KALLIKREIN; KININ; KININOGEN; POLYCLONAL ANTIBODY; SEPHAROSE; WHEAT GERM AGGLUTININ;

ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; CORONARY ARTERY; DOG; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; HEART; HEART MUSCLE; HEART MUSCLE PERFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOGENATE; IMMUNOBLOTTING; MOLECULAR WEIGHT; NONHUMAN; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STAINING; TEMPERATURE;

EID: 0031010884     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715060-00014     Document Type: Article

References (33)

1. Parratt JR: Cardioprotection by angiotensin converting enzyme inhibitors: the experimental evidence. Cardiovasc Res 1994, 28:183-189
2. Arakawa K, Maruta M: Ability of kallikrein to generate angiotensin II-like pressure substance and a proposed 'kinin-tensin enzyme system'. Nature 1980, 288:705-706.
3. Ikeda M, Arakawa K: Kininogenase activity of tonin. Hypertension 1980, 6:222-228.
4. Ideishi M, Ikeda M, Arakawa K: Direct angiotensin II formation by rat submandibular gland kallikrein. J Biochem (Tokyo) 1987, 102:859-868.
5. Ideishi M, Sasaguri M, Ikeda M, Arakawa K: Angiotensin-converting activity of tissue kallikrein. Nephron 1990, 55 (suppl 1):62-64.
6. Sasaguri M, Ideishi M, Ogata S, Miura S, Ikeda M, Arakawa K: Human urinary kallikrein can generate angiotensin II from homologous renin substrates. Hypertens Res 1995, 18:33-37.
7. Okunishi H, Miyazaki M, Okamura T, Toda N: Different distribution of two types of angiotensin-II generating enzymes in the aortic wall. Biochem Biophys Res Commun 1987, 149:1186-1192.
8. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990, 265: 22348-22357.
9. Gondo M, Maruta H, Arakawa K: Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart. Jap Heart J 1989, 30:219-229.
10. Noda K, Sasaguri M, Ideishi M, Ikeda M, Arakawa K: Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 1993, 27:334-340.
11. Hartmann JC, Hullinger TG, Wall TM, Shebuski RJ: Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition. Eur J Pharmacol 1993, 234:229-236.
12. Martorana PA, Kettenbach B, Breipohl G, Linz W, Schölkens BA: Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 1990, 182:395-396.
13. Nolly H, De Vito E, Cabrera R, Koninckx A: Kinin-releasing enzyme in cardiac tissue. In Hypertension. Edited by Villareal H. New York: John Wiley and Sons; 1981:75-84.
14. Britos J, Nolly H: Kinin-forming enzyme of rat cardiac tissue. Subcellular distribution and biochemical properties. Hypertension 1981, 3 (suppl II):II42-II45.
15. Xiong W, Chen LM, Woodley-Miller C, Simson JAV, Chao J: Identification, purification, and localization of tissue kallikrein in rat heart. Biochem J 1990, 267:639-646.
16. Moshi MI, Zeitlin U, Wainwright CL, Parratt JR: Acid optimum kininogenases in canine myocardium and aorta. Cardiovasc Res 1992, 26:367-370.
17. Miura S, Tashiro E, Sakai T, Koga M, Kinoshita A, Sasagun M, et al.: Urinary kallikrein activity is increased during the first few weeks of exercise training in essential hypertension. J Hypertens 1994, 12:815-823.
18. Takahashi T, Tang J: Cathepsin D from porcine and bovine spleen. Methods Enzymol 1981, 80:565-581.
19. Kitakaze M, Minamino T, Node K, Komamura K, Shinozaki Y, Mori H, et al.: Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation 1995, 92:950-961.
20. Murthy KK, Carretero OA, Scicli AG: Purification and characterization of canine urinary kallikrein. Arch Biochem Biophys 1986, 244:563-571.
21. Deperthes D, Gauthier ER, Chapdelaine P, Lazure C, Tremblay RR, Dube JY: Identification of glandular kallikrein in dog pancreas and determination of its tissue distribution. Biochim Biophys Acta 1995, 1243:291-294.
22. Baumgarten CR, Linz W, Kunkel G, Schölkens BA, Wiemer G: Ramiprilat increases bradykinin outflow from isolated hearts of rats. Br J Pharmacol 1993, 108:293-295.
23. Oza NB, Schwarz JA, Gould HD, Levinsky NG: Rat aortic smooth muscle cells in culture express kallikrein-kininogen and bradykinase activity. J Clin Invest 1990, 85:597-600.
24. Madeddu P, Gherli T, Bacciu PP, Maioli M, Glorioso N: A kallikrein-like enzyme in human vascular tissue. Am J Hypertens 1993, 6: 344-348.
25. Groves P, Kurz S, Just H, Drexlerr H: Roles of endogenous bradykinin in human coronary vasomotor control. Circulation 1995, 92:3424-3430.
26. Urabe Y, Ideishi M, Sasaguri M, Ikeda M, Arakawa K. Beneficial effects of nafamostat, a serine protease inhibitor, in patients with peripheral vascular disease. Am J Cardiol 1993, 72:218-222.
27. Miura S, Ideishi M, Sakai T, Motoyama M, Kinoshita A, Sasaguri M, et al.: Angiotensin II formation by an alternative pathway during exercise in humans. J Hypertens 1994, 12:1177-1181.
28. Campbell DJ: Metabolism of Prorenin, Renin, Angiotensinogen, and the Angiotensins by Tissues. In The Renin-Angiotensin System. Edited by Robertson JIS, Nicholls MG. London and New York: Gower Medical Publishing; 1993:23.1-23.23.
29. Arakawa K: Serine protease angiotensin II systems. J Hypertens 1996, 14 (suppl 5):S3-S7.
30. Kinoshita A, Urata H, Bumpus M, Husain A: Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart. J Biol Chem 1991, 266:19192-19197.
31. Klickstein LB, Kaempfer CE, Wintroub BU: The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G. J Biol Chem 1982, 257:15042-15046.
32. Tonnesen MG, Klempner MS, Austen F, Wintroub BU: Identification of a human neutrophil angiotensin II-generating protease as cathepsin G. J Clin Invest 1982, 69:25-30.
33. Reilly CF, Schechter NB, Travis J: Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase. Biochem Biophys Res Commun 1985, 127:443-449.